A lawsuit was filed on behalf of investors in Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares over alleged securities laws violations.

San Diego, CA -- (SBWire) -- 04/26/2022 --An investor, who purchased shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), filed a lawsuit over alleged violations of Federal Securities Laws by Aurinia Pharmaceuticals Inc.

Investors who purchased a shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) have certain options and for certain investors are short and strict deadlines running. Deadline: June 14, 2022. NASDAQ: AUPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Canada based Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally.

On February 28, 2022, Aurinia Pharmaceuticals Inc. announced its financial results for the quarter and full year ended December 31, 2021. Among other items, Aurinia reported a year-over-year revenue decline and announced a lower-than-expected sales outlook for 2022. Shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) declined from $33.97 per share on November 3, 2021, to as low as $9.91 per share on March 15, 2022.

The plaintiff claims that between May 7, 2021 and February 25, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that Aurinia Pharmaceuticals Inc was experiencing declining revenues, that Aurinia Pharmaceuticals Inc's 2022 sales outlook for LUPKYNIS would fall well short of expectations, that accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects, that as a result, the Company had overstated its financial position and/or prospects for 2022, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.